Cargando…

Full seroconversion in initial non-responders with higher antibody levels after heterologous COVID-19 vaccination schedule.

Antibody testing after COVID-19 vaccination is generally not recommended. Here, we present the results of a retrospective study, in which we analyzed antibody levels before and after the first dose of the ChAdOx1 vector vaccine. We identified 5% non-responders (43.6 ± 10.6 years; females: 41%) and 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Angelika, Ohradanova-Repic, Anna, Gebetsberger, Laura, Tajti, Gabor, Kundi, Michael, Stockinger, Hannes, Wiedermann, Ursula, Grabmeier-Pfistershammer, Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. on behalf of European Federation of Immunological Societies. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468054/ https://www.ncbi.nlm.nih.gov/pubmed/36108774 http://dx.doi.org/10.1016/j.imlet.2022.09.001

Ejemplares similares

Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense
por: Ohradanova-Repic, Anna, et al.
Publicado: (2023)

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
por: Ohradanova-Repic, Anna, et al.
Publicado: (2022)

Preexisting anti-PF4 antibodies are not further triggered upon vaccination with SARS-CoV-2 vector vaccines in a cohort of 400 health care workers
por: Angelika, Wagner, et al.
Publicado: (2022)

SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease
por: Wagner, Angelika, et al.
Publicado: (2022)

SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year
por: Garner-Spitzer, Erika, et al.
Publicado: (2022)

Editorial: Role of Metabolism in Regulating Immune Cell Fate Decisions
por: Ohradanova-Repic, Anna, et al.
Publicado: (2020)

Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel
por: Ohradanova-Repic, Anna, et al.
Publicado: (2016)

M2 Polarization of Human Macrophages Favors Survival of the Intracellular Pathogen Chlamydia pneumoniae
por: Buchacher, Tanja, et al.
Publicado: (2015)

Vaccine based on folded RBD‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants
por: Gattinger, Pia, et al.
Publicado: (2022)

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules
por: Wagner, Angelika, et al.
Publicado: (2018)

Lack of Induction of RBD-Specific Neutralizing Antibodies despite Repeated Heterologous SARS-CoV-2 Vaccination Leading to Seroconversion and Establishment of T Cell-Specific Memory in a Patient in Remission of Multiple Myeloma
por: Kratzer, Bernhard, et al.
Publicado: (2022)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

IgG4 drives M2a macrophages to a regulatory M2b‐like phenotype: potential implication in immune tolerance
por: Bianchini, Rodolfo, et al.
Publicado: (2018)

The mannose 6‐phosphate/insulin‐like growth factor 2 receptor mediates plasminogen‐induced efferocytosis
por: Ohradanova‐Repic, Anna, et al.
Publicado: (2019)

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021)

Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022
por: Wagner, Angelika, et al.
Publicado: (2023)

Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
por: Gattinger, Pia, et al.
Publicado: (2023)

SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023)

Late versus non-late presentation of HIV/AIDS: an economic impact analysis
por: Grabmeier-Pfistershammer, K, et al.
Publicado: (2010)

Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
por: Taylor, Ninon, et al.
Publicado: (2013)

Prime-Boost Vaccination with Toxoplasma Lysate Antigen, but Not with a Mixture of Recombinant Protein Antigens, Leads to Reduction of Brain Cyst Formation in BALB/c Mice
por: Wagner, Angelika, et al.
Publicado: (2015)

Oocyst-Derived Extract of Toxoplasma Gondii Serves as Potent Immunomodulator in a Mouse Model of Birch Pollen Allergy
por: Wagner, Angelika, et al.
Publicado: (2016)

Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2018)

Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
por: Parker, Edward P K, et al.
Publicado: (2022)

Risk Assessment and Epidemiologic Evidence: Kundi Responds
por: Kundi, Michael
Publicado: (2006)

Not All Immune Checkpoints Are Created Equal
por: De Sousa Linhares, Annika, et al.
Publicado: (2018)

Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report
por: Grabmeier-Pfistershammer, K., et al.
Publicado: (2012)

FcγR requirements and costimulatory capacity of Urelumab, Utomilumab, and Varlilumab
por: Leitner, Judith, et al.
Publicado: (2023)

Full FTS Service Deployment Schedule & Issues
por: Fisk (Convenor), Ian, et al.
Publicado: (2007)

Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia
por: Stojanovic, Marijana, et al.
Publicado: (2020)

The Role of Alveolar Epithelial Type II-Like Cells in Uptake of Structurally Different Antigens and in Polarisation of Local Immune Responses
por: Akgün, Johnnie, et al.
Publicado: (2015)

Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
por: Lagler, H, et al.
Publicado: (2010)

Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation
por: Garner-Spitzer, Erika, et al.
Publicado: (2023)

Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV
por: Wang, Yi, et al.
Publicado: (2023)

The Association of Time of Day of ChAdOx1 nCoV-19 Vaccine Administration With SARS-CoV-2 Anti-Spike IgG Antibody Levels: An Exploratory Observational Study
por: Erber, Astrid C., et al.
Publicado: (2022)

TIM-3 Does Not Act as a Receptor for Galectin-9
por: Leitner, Judith, et al.
Publicado: (2013)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
por: Battin, Claire, et al.
Publicado: (2022)

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017)

Primary vaccine failure to routine vaccines: Why and what to do?
por: Wiedermann, Ursula, et al.
Publicado: (2016)

A re-examination of responding on ratio and regulated-probability interval schedules
por: Pérez, Omar D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_smoq2tsb27los4i2nm9s7do291